GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK statistics
99 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- Aug 13, 2026
- Fundamentals through
- Dec 31, 2025
- Share price as of
- –
Valuation ratiosIndustry
- P/OCF Ratio
- 10.32
- –
Enterprise valuationIndustry
- EV / Sales
- 2.87
- –
- EV / EBIT
- 11.82
- –
- EV / FCF
- 14.67
- –
Share statisticsIndustry
- Shares Change (YoY)
- -0.60%
- –
- Float
- 4.31B
- –
- Shares Held by Insiders
- 0.05%
- –
- Shares Held by Institutions
- 8.03%
- –
Short sellingIndustry
- Short Interest
- 15M
- –
- Short Interest Change
- -1.47%
- –
- Days to Cover
- 2.14
- –
Stock price statisticsIndustry
- Price Change (1 Week)
- -2.44%
- –
- Price Change (1 Month)
- 4.94%
- –
- Price Change (3 Months)
- -3.88%
- –
- Price Change (6 Months)
- -4.07%
- –
- Price Change (YTD)
- 0.96%
- –
- Price Change (1 Year)
- 7.79%
- –
- Price Change (3 Years)
- 43.8%
- –
- Price Change (5 Years)
- -7.23%
- –
- Price Change (10 Years)
- 4.24%
- –
- Average Volume (10 Days)
- 5M
- –
- Average Volume (20 Days)
- 6M
- –
- Average Volume (90 Days)
- 4M
- –
- Relative Volume
- 1.14
- –
- Relative Strength Index (14)
- 51.2
- –
- Volatility (1 Year)
- 26.0%
- –
- Beta (5 Years)
- 0.27
- –
MarginsIndustry
- Pretax Margin
- 22.7%
- –
- EBITDA Margin
- 31.4%
- –
- FCF Margin
- 19.6%
- –
Returns on capitalIndustry
- Return on Equity (ROE)
- 38.0%
- –
- Return on Assets (ROA)
- 9.48%
- –
- Return on Invested Capital (ROIC)
- 23.4%
- –
- Return on Capital Employed (ROCE)
- 20.0%
- –
Financial positionIndustry
- Current Ratio
- 0.82
- –
- Quick Ratio
- 0.51
- –
- Debt / Equity
- 1.08
- –
- Debt / EBITDA
- 1.73
- –
- Debt / FCF
- 2.77
- –
- Net Debt / EBITDA
- 1.40
- –
- Interest Coverage
- 11.32
- –
GrowthIndustry
- Revenue Growth (YoY)
- 4.11%
- –
- Net Income Growth (YoY)
- 122.0%
- –
- EPS Growth (YoY)
- 123.2%
- –
- FCF Growth (YoY)
- 24.0%
- –
- Revenue Growth (3Y CAGR)
- 3.66%
- –
- Revenue Growth (5Y CAGR)
- 6.05%
- –
- EPS Growth (3Y CAGR)
- -27.6%
- –
- EPS Growth (5Y CAGR)
- -0.54%
- –
EfficiencyIndustry
- Asset Turnover
- 0.54
- –
- Inventory Turnover
- 1.56
- –
- Revenue Per Employee
- £65.33K
- –
- Profits Per Employee
- £11.43K
- –
- Employee Count
- 500,000
- –
- WACC
- 6.89%
- –
Income statement (TTM)Industry
- Pretax Income
- £7.40B
- –
Balance sheetIndustry
- Net Cash (Debt)
- -£14.32B
- –
- Net Cash Per Share
- -3.32 GBP
- –
- Equity (Book Value)
- £16.38B
- –
- Book Value Per Share
- 3.79 GBP
- –
- Tangible Book Value
- -£7.39B
- –
- Working Capital
- -£3.88B
- –
Cash flow (TTM)Industry
- Capital Expenditures
- -£1.35B
- –
- FCF Per Share
- 1.48 GBP
- –
Dividends and yieldsIndustry
- Earnings Yield
- 7.16%
- –
- FCF Yield
- 8.00%
- –
- Buyback Yield
- 1.71%
- –
- Shareholder Yield
- 1.71%
- –
- Payout Ratio
- 44.9%
- –
- FCF Payout Ratio
- 40.1%
- –
Taxes and interestIndustry
- Interest Expense
- £701.00M
- –
- Income Tax
- £1.11B
- –
- Effective Tax Rate
- 15.0%
- –
Scores and fair valueIndustry
- Graham Number
- 10.89 GBP
- –
- Graham Upside
- -41.2%
- –
- Altman Z-Score
- 2.18
- –
- Piotroski F-Score
- 9
- –
- Beneish M-Score
- -2.46
- –
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | GLAXF | S&P 500 | Difference | GLAXF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.8% | +0.6% | −1.5 pts | ||
| 3 months | -3.1% | +3.4% | −6.5 pts | ||
| Year to date | +2.3% | +13.3% | −11.0 pts | ||
| 1 year | +15.9% | +16.6% | −0.7 pts | ||
| 3 years | +55.5% | +86.4% | −30.8 pts | +15.9% | +23.1% |
| 5 years | +24.6% | +81.9% | −57.3 pts | +4.5% | +12.7% |
| 10 years | +51.4% | +318.9% | −267.4 pts | +4.2% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
1M GLAXF shares were sold short on Oct 15, 2026, up 0.9% from the previous report. At recent volumes it would take 329.5 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 1,206,201 | +0.9% | 3,661 | 329.5 |
| Sep 30, 2026 | 1,195,633 | +12.1% | 1,405 | 851.0 |
| Sep 15, 2026 | 1,066,801 | -8.7% | 2,689 | 396.7 |
| Aug 31, 2026 | 1,168,148 | -8.1% | 1,708 | 683.9 |
| Aug 14, 2026 | 1,270,692 | +50.6% | 1,201 | 1000.0 |
| Jul 31, 2026 | 843,521 | -22.3% | 621 | 1000.0 |
| Jul 15, 2026 | 1,085,826 | +3.6% | 795 | 1000.0 |
| Jun 30, 2026 | 1,048,477 | +1.7% | 3,291 | 318.6 |
| Jun 15, 2026 | 1,030,650 | +18.3% | 1,909 | 539.9 |
| May 29, 2026 | 871,078 | +13.6% | 1,352 | 644.3 |
| May 15, 2026 | 767,005 | -54.3% | 1,682 | 456.0 |
| Apr 30, 2026 | 1,678,201 | -4.8% | 2,314 | 725.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.